CRUSE

chronic urticaria self evaluation (CRUSE®) app digital tools mHealth apps patient-reported outcome measures wheals and angioedema

Journal

Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043

Informations de publication

Date de publication:
Jan 2024
Historique:
revised: 15 12 2023
received: 11 11 2023
accepted: 18 12 2023
medline: 29 1 2024
pubmed: 29 1 2024
entrez: 28 1 2024
Statut: ppublish

Résumé

Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user-friendly platform to complete patient-reported outcome measures (PROMs) on their mobile devices. CRUSE CRUSE CRUSE The initial data from CRUSE

Sections du résumé

BACKGROUND BACKGROUND
Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user-friendly platform to complete patient-reported outcome measures (PROMs) on their mobile devices. CRUSE
METHODS METHODS
CRUSE
RESULTS RESULTS
CRUSE
CONCLUSIONS CONCLUSIONS
The initial data from CRUSE

Identifiants

DOI: 10.1002/clt2.12328 PMID: 38282190
pubmed: 38282190
doi: 10.1002/clt2.12328
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12328

Subventions

Organisme : Moxie
Organisme : Celldex Therapeutics
Organisme : UCARE (Urticaria Centers of Reference and Excellence)
Organisme : Novartis

Informations de copyright

© 2024 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

Références

Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. (In eng). https://doi.org/10.1111/all.15090
Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75(2):423-432. (In eng). https://doi.org/10.1111/all.14037
Klyucharova A, Martynova E, Rizvanov A, Khaiboullina S. Exacerbation of chronic spontaneous urticaria symptoms in COVID-19 patients, case report. Bionanoscience. 2022;12(4):1482-1488. (In eng). https://doi.org/10.1007/s12668-022-01007-8
Schut C, Magerl M, Hawro T, et al. Disease activity and stress are linked in a subpopulation of chronic spontaneous urticaria patients. Allergy. 2020;75(1):224-226. (In eng). https://doi.org/10.1111/all.14015
Kocatürk E, Salman A, Cherrez-Ojeda I, et al. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy. 2021;76(3):816-830. (In eng). https://doi.org/10.1111/all.14687
Balp MM, Halliday AC, Severin T, et al. Clinical remission of chronic spontaneous urticaria (CSU): a targeted literature review. Dermatol Ther (Heidelb). 2022;12(1):15-27. (In eng). https://doi.org/10.1007/s13555-021-00641-6
Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226-236. (In eng). https://doi.org/10.1111/bjd.19561
Maurer M, Staubach P, Raap U, Richter-Huhn G, Baier-Ebert M, Chapman-Rothe N. ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice. Br J Dermatol. 2016;174(4):892-894. (In eng). https://doi.org/10.1111/bjd.14203
Maurer M, Abuzakouk M, Bérard F, et al. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017;72(12):2005-2016. (In eng). https://doi.org/10.1111/all.13209
Maurer M, Staubach P, Raap U, et al. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study. Clin Exp Allergy. 2017;47(5):684-692. (In eng). https://doi.org/10.1111/cea.12900
Weller K, Siebenhaar F, Hawro T, Altrichter S, Schoepke N, Maurer M. Clinical measures of chronic urticaria. Immunol Allergy Clin. 2017;37(1):35-49. (In eng). https://doi.org/10.1016/j.iac.2016.08.005
Baiardini I, Giardini A, Pasquali M, et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy. 2003;58(7):621-623. (In eng). https://doi.org/10.1034/j.1398-9995.2003.00091.x
O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136(2):197-201. (In eng). https://doi.org/10.1111/j.1365-2133.1997.tb14895.x
Giménez-Arnau A, Maurer M, Bernstein J, et al. Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria. Clin Transl Allergy. 2022;12(2):e12121. (In eng). https://doi.org/10.1002/clt2.12121
Tzur Bitan D, Berzin D, Cohen A. The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study. Arch Dermatol Res. 2021;313(1):33-39. (In eng). https://doi.org/10.1007/s00403-020-02064-3
Hopkinson K. The role of patient-reported outcomes in the management of chronic spontaneous urticaria. Br J Nurs. 2019;28(3):144-150. (In eng). https://doi.org/10.12968/bjon.2019.28.3.144
Kornowski R. Patient-reported outcome measures in cardiovascular disease. Eur Heart J Qual Care Clin Outcomes. 2023;9(2):119-127. (In eng). https://doi.org/10.1093/ehjqcco/qcab051
Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63(6):777-780. (In eng). https://doi.org/10.1111/j.1398-9995.2008.01726.x
Hawro T, Ohanyan T, Schoepke N, et al. Comparison and interpretability of the available urticaria activity scores. Allergy. 2018;73(1):251-255. (In eng). https://doi.org/10.1111/all.13271
Weller K, Groffik A, Magerl M, et al. Development, validation, and initial results of the angioedema activity score. Allergy. 2013;68(9):1185-1192. (In eng). https://doi.org/10.1111/all.12209
Weller K, Groffik A, Church MK, et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133(5):1365-1372. 1372.e1-6. (In eng). https://doi.org/10.1016/j.jaci.2013.12.1076
Ohanyan T, Schoepke N, Bolukbasi B, et al. Responsiveness and minimal important difference of the urticaria control test. J Allergy Clin Immunol. 2017;140(6):1710-1713.e11. (In eng). https://doi.org/10.1016/j.jaci.2017.04.050
Weller K, Donoso T, Magerl M, et al. Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy. 2020;75(5):1165-1177. (In eng). https://doi.org/10.1111/all.14144
Weller K, Donoso T, Magerl M, et al. Validation of the angioedema control test (AECT)-A patient-reported outcome instrument for assessing angioedema control. J Allergy Clin Immunol Pract. 2020;8(6):2050-2057.e4. (In eng). https://doi.org/10.1016/j.jaip.2020.02.038
Weller K, Schoepke N, Krause K, Ardelean E, Bräutigam M, Maurer M. Selected urticaria patients benefit from a referral to tertiary care centres--results of an expert survey. J Eur Acad Dermatol Venereol. 2013;27(1):e8-e16. (In eng). https://doi.org/10.1111/j.1468-3083.2011.04387.x
Weller K, Viehmann K, Bräutigam M, et al. Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients. J Dtsch Dermatol Ges. 2012;10(5):341-347. (In eng). https://doi.org/10.1111/j.1610-0387.2011.07822.x
Marcus Maurer JB, Robles-Velasco K. Barriers of use of PROMs among allergists who treat atopic dermatitis and chronic urticaria. Ann Allergy Asthma Immunol. 2022;129(5):S33-S34. https://doi.org/10.1016/j.anai.2022.08.600
Ansah JP, Chiu CT. Projecting the chronic disease burden among the adult population in the United States using a multi-state population model. Front Public Health. 2022;10:1082183. (In eng). https://doi.org/10.3389/fpubh.2022.1082183
Antó A, Maurer R, Gimenez-Arnau A, et al. Automatic screening of self-evaluation apps for urticaria and angioedema shows a high unmet need. Allergy. 2021;76(12):3810-3813. (In eng). https://doi.org/10.1111/all.15061
Maurer M, Metz M, Bindslev-Jensen C, et al. Definition, aims, and implementation of GA(2) LEN urticaria Centers of reference and excellence. Allergy. 2016;71(8):1210-1218. (In eng). https://doi.org/10.1111/all.12901
Rosenlund M, Kinnunen UM, Saranto K. The use of digital health services among patients and citizens living at home: scoping review. J Med Internet Res. 2023;25:e44711. (In eng). https://doi.org/10.2196/44711
Cherrez-Ojeda I, Vanegas E, Cherrez A, et al. Chronic urticaria patients are interested in apps to monitor their disease activity and control: a UCARE CURICT analysis. Clin Transl Allergy. 2021;11(10):e12089. (In eng). https://doi.org/10.1002/clt2.12089
Cherrez-Ojeda I, Vanegas E, Cherrez A, et al. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ J. 2021;14(6):100542. (In eng). https://doi.org/10.1016/j.waojou.2021.100542
Bousquet J, Anto JM, Sousa-Pinto B, et al. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: the ARIA-MASK-air(®) approach. Clin Transl Allergy. 2023;13(1):e12215. (In eng). https://doi.org/10.1002/clt2.12215
Bousquet J, Samolinski B, Kaidashev I, et al. UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan. Allergy. 2023. (In eng). https://doi.org/10.1111/all.15855
Maurer M, Eyerich K, Eyerich S, et al. Urticaria: collegium internationale allergologicum (CIA) update 2020. Int Arch Allergy Immunol. 2020;181(5):321-333. (In eng). https://doi.org/10.1159/000507218
Fijen LM, Vera C, Buttgereit T, et al. Sensitivity to change and minimal clinically important difference of the angioedema control test. Clin Transl Allergy. 2023;13(9):e12295. (In eng). https://doi.org/10.1002/clt2.12295
Vanya M, Watt M, Shahraz S, et al. Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema. J Patient Rep Outcomes. 2023;7(1):33. (In eng). https://doi.org/10.1186/s41687-023-00576-w
Maurer M, Weller K, Magerl M, et al. The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: a UCARE study. World Allergy Organ J. 2020;13(11):100475. (In eng). https://doi.org/10.1016/j.waojou.2020.100475
Kolkhir P, Laires PA, Salameh P, et al. The benefit of complete response to treatment in patients with chronic spontaneous urticaria-CURE results. J Allergy Clin Immunol Pract. 2023;11(2):610-620.e5. (In eng). https://doi.org/10.1016/j.jaip.2022.11.016
Sousa-Pinto B, Eklund P, Pfaar O, et al. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021;11(7):e12062. (In eng). https://doi.org/10.1002/clt2.12062
Deps P, Charlier P. Medical approach to refugees: importance of the caring physician. Ann Glob Health. 2020;86(1):41. (In eng). https://doi.org/10.5334/aogh.2779
Poppleton A, Ougrin D, Maksymets Y. Providing responsive primary care for Ukrainian refugees. Br J Gen Pract. 2022;72(719):274-275. (In eng). https://doi.org/10.3399/bjgp22X719633
Vaportzis E, Clausen MG, Gow AJ. Older adults perceptions of technology and barriers to interacting with tablet computers: a focus group study. Front Psychol. 2017;8:1687. (In eng). https://doi.org/10.3389/fpsyg.2017.01687
Weller K, Giménez-Arnau A, Grattan C, et al. The Chronic Urticaria Registry: rationale, methods and initial implementation. J Eur Acad Dermatol Venereol. 2021;35(3):721-729. (In eng). https://doi.org/10.1111/jdv.16947

Auteurs

Sophia Neisinger (S)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
ORCID: 0009-0000-5967-4809

Bernardo Sousa Pinto (B)

Faculty of Medicine, MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, University of Porto, Porto, Portugal.
CINTESIS-Center for Health Technology and Services Research, University of Porto, Porto, Portugal.
RISE-Health Research Network, University of Porto, Porto, Portugal.
ORCID: 0000-0002-1277-3401

Aiste Ramanauskaite (A)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
ORCID: 0009-0004-9289-5960

Jean Bousquet (J)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Faculty of Medicine, MEDCIDS-Department of Community Medicine, Information and Health Decision Sciences, University of Porto, Porto, Portugal.
ORCID: 0000-0002-4061-4766

Karsten Weller (K)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
ORCID: 0000-0003-4437-0313

Martin Metz (M)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
ORCID: 0000-0002-4070-9976

Markus Magerl (M)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
ORCID: 0000-0001-9218-5468

Emek Kocatürk (E)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Department of Dermatology, UCARE, Koç University School of Medicine, Istanbul, Turkey.
ORCID: 0000-0003-2801-0959

Ivan Cherrez-Ojeda (I)

Universidad Espíritu Santo, Respiralab Research Center, Guayaquil, Ecuador.
ORCID: 0000-0002-1610-239X

Ana M Gimenez-Arnau (AM)

Department of Dermatology, UCARE, Hospital del Mar and Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
ORCID: 0000-0001-5434-7753

Claudio Alberto S Parisi (CAS)

Adult and Pediatric Allergy Sections of the Italian Hospital of Buenos Aires, Buenos Aires, Argentina.

Sabine Altrichter (S)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
Department of Dermatology and Venerology, UCARE, Kepler University Hospital, Linz, Austria.
Faculty of Medicine, Center for Medical Research, Johannes Kepler University, Linz, Austria.
ORCID: 0000-0001-9955-385X

Luis Felipe Ensina (LF)

Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil.

Laurence Bouillet (L)

National Reference Center for Angioedema, Internal Medicine Department, Grenoble University Hospital, Grenoble, France.

Riccardo Asero (R)

Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy.

Margarida Gonçalo (M)

Faculty of Medicine, Coimbra University Hospital, University of Coimbra, Coimbra, Portugal.
ORCID: 0000-0001-6842-1360

Carole Guillet (C)

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

Krzysztof Rutkowski (K)

Urticaria Clinic, St John's Institute of Dermatology, Guy's and St Thomas' Hospital, London, UK.

Jonathan A Bernstein (JA)

Division of Rheumatology, Allergy and Immunology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Hannah Hardin (H)

Ohio University Heritage College of Osteopathic Medicine, Cleveland, Ohio, USA.

Kiran Godse (K)

Department of Dermatology, Dr D Y Patil Medical College and Hospital, Navi Mumbai, India.

Zenon Brzoza (Z)

Division of Allergology, Department of Internal Diseases, Institute of Medical Sciences, University of Opole, Opole, Poland.

Jose Ignacio Larco Sousa (JIL)

Department of Allergy, UCARE, Clinica San Felipe, Lima, Peru.

Simon Francis Thomsen (SF)

Department of Biomedical Sciences, Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
ORCID: 0000-0002-4838-300X

Martijn van Doorn (M)

Department of Dermatology, UCARE, Erasmus MC, Rotterdam, The Netherlands.

Michihiro Hide (M)

Department of Dermatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.

Young-Min Ye (YM)

Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.

Staffan Vandersee (S)

Dermatologie/Venerologie, Bundeswehrkrankenhaus Berlin, Akademisches Lehrkrankenhaus der Charité, Berlin, Germany.

Lāsma Lapiņa (L)

Allergic Diseases Diagnosis and Treatment Center, Riga Stradins University, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Jonny Peter (J)

ACARE Centre, Division of Allergy and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
ORCID: 0000-0002-2658-0723

Zuotao Zhao (Z)

Department of Dermatology and Venerology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, Peking University First Hospital, Beijing, China.
ORCID: 0000-0002-9595-6050

Lianyi Han (L)

Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Shanghai, China.

Iman Nasr (I)

Department of Clinical Immunology and Allergy, Royal Hospital, Muscat, Oman.

Heike Rockmann-Helmbach (H)

Department of Dermatology/Allergology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Jennifer Astrup Sørensen (JA)

Department of Biomedical Sciences, Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.

Rabia Öztaş Kara (RÖ)

Department of Dermatology, Sakarya University Faculty of Medicine, Sakarya, Turkey.

Natalja Kurjāne (N)

Allergic Diseases Diagnosis and Treatment Center, Riga Stradins University, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Andrii I Kurchenko (AI)

Department of Clinical and Laboratory Immunology, Allergology and Medical Genetics, Bogomolets National Medical University, Kyiv, Ukraine.

Igor Kaidashev (I)

Poltava State Medical University, Poltava, Ukraine.

Vladyslav Tsaryk (V)

Department of Clinical and Laboratory Immunology, Allergology and Medical Genetics, Bogomolets National Medical University, Kyiv, Ukraine.

Roman Stepanenko (R)

Department of Dermatology and Venereology with Cosmetology Course, Bogomolets National Medical University, Kyiv, Ukraine.

Marcus Maurer (M)

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
ORCID: 0000-0002-4121-481X

Classifications MeSH